Deep Dive: U.S. Measles Cases Reach 5,182 — Highest Since 1991 — Background, What Changed, Viewpoints, and What to Watch

Deep Dive: U.S. Measles Cases Reach 5,182 — Highest Since 1991

Parenting · 7 November 2026

Background

The United States declared measles eliminated in 2000 after sustained high MMR vaccination coverage interrupted endemic transmission. For two decades, cases were almost entirely imported. That changed as kindergarten MMR coverage fell from 95.2% in 2019–2020 to 92.4% in 2025–2026, leaving roughly 280,000 kindergartners unprotected each year.

By early November 2026 the CDC had confirmed 5,182 measles cases — the highest annual total since 1991 and more than double the 2,289 cases recorded in all of 2025. Ninety-six percent of cases are outbreak-associated. Children and teens account for about 59% of infections. Hospitalizations stand at 11% (562 patients).

What Changed This Week

On 5–6 November the CDC updated its count to 5,182 after 330 new cases in a single week — the 13th consecutive week of triple-digit increases. Pennsylvania reported 1,487 cases and its sixth measles-associated death. Wisconsin confirmed its first measles death since 1990 (an infant) and 477 cases. New York reported a 7-month-old death, its first in more than 30 years.

State health departments have now documented at least eight measles-associated deaths in 2026, while the CDC has confirmed only four. The discrepancy is under review. The Pan American Health Organization’s Regional Verification Commission is scheduled to meet 10–13 November; continuous transmission beyond 12 months in any jurisdiction would end the U.S. elimination status.

Competing Viewpoints

Public-health authorities emphasize that two doses of MMR are 97% effective and that the current wave is almost entirely among unvaccinated or unknown-status individuals. They point to the recent cluster of pediatric deaths as evidence that the virus remains capable of severe harm when coverage drops below the 95% threshold needed for community protection.

Some parents and advocacy groups frame refusal as a personal or religious choice and question the risk–benefit balance of routine vaccination. A smaller number of clinicians note that early MMR dosing (from 6 months) is now recommended in outbreak counties, which adds logistical complexity for families.

What to Watch Next

1. PAHO’s 10–13 November review and any formal determination on U.S. elimination status.
2. Whether additional states recommend early MMR dosing for infants 6–11 months in active outbreak areas.
3. Updated CDC death counts as state reports are reconciled.
4. Co-circulation with early flu and RSV and the capacity of pediatric hospitals.

Parents in or near outbreak counties should confirm MMR status for everyone in the household, including older children and adults, and discuss early dosing with their clinician if local guidance supports it. Isolation after exposure remains the primary tool for unprotected infants too young for vaccine.